The USAN program is a collaborative effort between the American Medical Association (AMA), the United States Pharmacopeial Convention (USP), and the American Pharmacists Association (APhA). The process involves:
Submission of a name proposal by the drug's manufacturer. Review by the USAN Council, which includes representatives from the AMA, USP, and APhA. Approval by the USAN Council and assignment of the name.